Origin Therapeutics Holdings (XCNQ:ORIG) Net Interest Income : C$0.09 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Origin Therapeutics Holdings's net interest income for the three months ended in Jun. 2023 was C$0.03 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.09 Mil.

Origin Therapeutics Holdings Net Interest Income Historical Data

The historical data trend for Origin Therapeutics Holdings's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Net Interest Income Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Net Interest Income

0.03

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Net Interest Income	Get a 7-Day Free Trial				0.02	0.01	0.02	0.03	0.03

Origin Therapeutics Holdings Net Interest Income Calculation

Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.09 Mil.

Origin Therapeutics Holdings Net Interest Income Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.